UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1367) 1367
science & technology (1129) 1129
life sciences & biomedicine (1093) 1093
male (1003) 1003
female (842) 842
pyrrolidines - therapeutic use (788) 788
pyrrolidines - adverse effects (651) 651
middle aged (617) 617
adult (540) 540
animals (503) 503
pyrrolidines - pharmacology (447) 447
aged (439) 439
biological and medical sciences (428) 428
medical sciences (410) 410
pyrrolidines - administration & dosage (403) 403
pharmacology & pharmacy (340) 340
adamantane - analogs & derivatives (313) 313
treatment outcome (291) 291
double-blind method (274) 274
diabetes mellitus, type 2 - drug therapy (256) 256
pharmacology. drug treatments (245) 245
rats (226) 226
dose-response relationship, drug (203) 203
adamantane - therapeutic use (197) 197
nitriles - therapeutic use (184) 184
pyrrolidines - pharmacokinetics (172) 172
abridged index medicus (167) 167
vildagliptin (166) 166
adolescent (165) 165
type 2 diabetes (158) 158
adamantane - adverse effects (156) 156
clinical trials as topic (154) 154
time factors (152) 152
hypoglycemic agents - therapeutic use (149) 149
nitriles - adverse effects (148) 148
neurosciences & neurology (147) 147
endocrinology & metabolism (143) 143
administration, oral (139) 139
drug therapy, combination (139) 139
dipeptidyl-peptidase iv inhibitors - therapeutic use (134) 134
drug therapy (130) 130
mice (126) 126
analysis (121) 121
care and treatment (118) 118
neurosciences (118) 118
pyrrolidines (116) 116
rats, sprague-dawley (110) 110
hypoglycemic agents - adverse effects (107) 107
diabetes mellitus, type 2 - blood (105) 105
diabetes (104) 104
research (102) 102
aged, 80 and over (99) 99
cardiovascular system & cardiology (98) 98
dipeptidyl-peptidase iv inhibitors - adverse effects (97) 97
oncology (94) 94
adamantane - administration & dosage (92) 92
medicine & public health (91) 91
clinical trials (88) 88
young adult (88) 88
nitriles - administration & dosage (87) 87
general & internal medicine (84) 84
cardiac & cardiovascular systems (83) 83
toxicology (82) 82
medicine, general & internal (81) 81
blood glucose - metabolism (80) 80
clinical neurology (80) 80
disease models, animal (80) 80
pyrrolidines - chemistry (80) 80
glycated hemoglobin a - metabolism (76) 76
migraine disorders - drug therapy (71) 71
internal medicine (70) 70
dosage and administration (68) 68
rodents (68) 68
health aspects (67) 67
psychiatry (67) 67
randomized controlled trials as topic (67) 67
hypoglycemic agents - administration & dosage (66) 66
pharmacokinetics (66) 66
hypoglycemic agents (64) 64
blood glucose - drug effects (63) 63
indoles - therapeutic use (63) 63
adamantane - pharmacology (61) 61
drug administration schedule (61) 61
glucose (61) 61
metformin - therapeutic use (61) 61
drug interactions (60) 60
atrial fibrillation - drug therapy (59) 59
prospective studies (59) 59
cardiovascular system (58) 58
cross-over studies (58) 58
drug combinations (58) 58
nitriles - pharmacology (58) 58
placebos (58) 58
blood pressure - drug effects (57) 57
endocrinopathies (57) 57
tryptamines (57) 57
sitagliptin phosphate (56) 56
triazoles - therapeutic use (56) 56
heart rate - drug effects (55) 55
medicine, research & experimental (55) 55
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1616) 1616
French (65) 65
German (33) 33
Japanese (20) 20
Italian (13) 13
Spanish (11) 11
Russian (7) 7
Portuguese (4) 4
Czech (3) 3
Dutch (3) 3
Chinese (2) 2
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Polish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 11/2019, Volume 381, Issue 19, pp. 1809 - 1819
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1940 - 1948
Double-Blind Method | Humans | yes | Pyridines/administration & dosage | Male | Pyrazoles/administration & dosage | Indoles/administration & dosage | Aminophenols/administration & dosage | Cystic Fibrosis Transmembrane Conductance Regulator/genetics | Cystic Fibrosis/drug therapy | Quinolones/administration & dosage | Adolescent | Sweat/chemistry | Female | Benzodioxoles/administration & dosage | Chloride Channel Agonists/administration & dosage | Drug Therapy, Combination | Child | Pyrrolidines/administration & dosage | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Chloride Channel Agonists - adverse effects | Benzodioxoles - administration & dosage | Aminophenols - adverse effects | Indoles - administration & dosage | Sweat - chemistry | Pyridines - adverse effects | Quinolones - adverse effects | Benzodioxoles - adverse effects | Pyrazoles - adverse effects | Pyridines - administration & dosage | Pyrazoles - administration & dosage | Quinolones - administration & dosage | Indoles - adverse effects | Chloride Channel Agonists - administration & dosage | Cystic Fibrosis - genetics | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Aminophenols - administration & dosage | Cystic Fibrosis - drug therapy | Clinical trials | Cystic fibrosis | Ivacaftor | Genetic aspects | Infections | Modulators | Defects | Quality of life | Resistance | Proteins | Randomization | Chloride | Chlorides | Fibrosis | Conductance | Mutation | Safety | Sweat | Active control | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 17, pp. 1599 - 1611
Journal Article
Journal of hepatology, ISSN 0168-8278, 2017, Volume 67, Issue 2, pp. 263 - 271
Journal Article
Annals of internal medicine, ISSN 0003-4819, 06/2012, Volume 156, Issue 12, pp. 861 - 874
Journal Article
Pharmacology, ISSN 0031-7012, 08/2010, Volume 86, Issue 1, pp. 44 - 57
Review | Glycemic control | Diabetes | Incretin mimetics | Hypoglycemia | Dipeptyl peptidase type 4 inhibitor | Weight | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - adverse effects | Nitriles - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Pyrrolidines - adverse effects | Pyrazines - therapeutic use | Weight Loss - drug effects | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Adamantane - therapeutic use | Adult | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Adamantane - pharmacology | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - pharmacology | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Triazoles - pharmacology | Pyrazines - adverse effects | Venoms - therapeutic use | Venoms - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Nitriles - adverse effects | Pyrazines - pharmacology | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Nitriles - therapeutic use | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2017, Volume 2017, Issue 2, pp. CD009966 - CD009966
Glomerular diseases | Adamantane | Dipeptidyl Peptidase 4 | Dipeptidyl‐Peptidase IV Inhibitors | Hypoglycemic Agents | Glycated Hemoglobin A | Child health | Glomerular disease | Pyrrolidines | Diabetes Mellitus, Type 1 | Nitriles | Diabetes Mellitus, Type 2 | Sitagliptin Phosphate | Diabetic kidney disease | Kidney disease | Fasting | Pharmacological interventions | Pioglitazone | Graft Survival | Kidney Transplantation | Chronic kidney disease | Hypoglycemia | Insulin | Randomized Controlled Trials as Topic | Vildagliptin | Medicine General & Introductory Medical Sciences | Thiazolidinediones | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Pyrrolidines - adverse effects | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Fasting - blood | Adamantane - therapeutic use | Hypoglycemia - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Thiazolidinediones - adverse effects | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 1 - blood | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Graft Survival - drug effects | Nitriles - adverse effects | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Sitagliptin Phosphate - adverse effects | Index Medicus
Journal Article